FDA Adverse Event
Injury
Summary report: N
FARAPULSE PULSED FIELD ABLATION SYSTEM
MDR report key: 20228451
·
Received September 13, 2024
Report
- Report Number
- MW5159637
- Event Type
- Injury
- Date Received
- September 13, 2024
- Report Date
- September 11, 2024
- Manufacturer
- BOSTON SCIENTIFIC CORPORATION
- Product Code
- QZI
- Adverse Event
- Yes
- Report Source
- Voluntary report
- Reporter Location
- MN, US
- Reporter Occupation
- OTHER
- Health Professional
- *
Narratives
Description of Event or Problem · 0
WE COMPLETED A PFA CASE USING BOSTON SCIENTIFIC'S FARAPULSE SYSTEM. DURING THE POST CASE ICE SURVEY, THE PHYSICIAN NOTICED A PERICARDIAL EFFUSION. THEY PERFORMED A PERICARDIAL SYNTHESIS AND MONITORED THE EFFUSION. PHYSICIAN BELIEVES THEY PERFED WITH THE BOSTON WIRE/PFA SYSTEM. THIS REPORT REFLECTS INFORMATION RECEIVED BY FDA IN THE FORM OF A NOTIFICATION PER 803.22 (B)(2).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1318405 | FARAPULSE PULSED FIELD ABLATION SYSTEM | PERCUTANEOUS CARDIAC ABLATION CATHETER FOR TREATMENT OF ATRIAL FIBRILLATION WITH | QZI | BOSTON SCIENTIFIC CORPORATION |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown |